Mettler-Toledo International (NYSE:MTD) Downgraded to “Hold” Rating by Wall Street Zen

Wall Street Zen cut shares of Mettler-Toledo International (NYSE:MTD) from a buy rating to a hold rating in a research report released on Saturday.

MTD has been the topic of a number of other research reports. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a report on Monday, December 15th. Evercore ISI increased their target price on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Citigroup raised their price target on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research report on Monday, November 10th. The Goldman Sachs Group began coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Finally, Morgan Stanley assumed coverage on Mettler-Toledo International in a report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price objective on the stock. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,441.67.

Mettler-Toledo International Stock Down 1.6%

Shares of NYSE MTD opened at $1,370.92 on Friday. The stock’s 50-day simple moving average is $1,432.30 and its two-hundred day simple moving average is $1,353.19. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,525.17. The firm has a market capitalization of $28.01 billion, a P/E ratio of 34.19, a P/E/G ratio of 4.14 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. The firm had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter last year, the company posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, research analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Shawn Vadala sold 1,000 shares of the stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $1,511.00, for a total transaction of $1,511,000.00. Following the completion of the sale, the chief financial officer directly owned 5,288 shares in the company, valued at $7,990,168. This represents a 15.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider La Guerroniere Marc De sold 6,055 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the transaction, the insider directly owned 187 shares in the company, valued at $278,289.66. This trade represents a 97.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 19,565 shares of company stock worth $28,683,737 in the last 90 days. 1.94% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Several institutional investors have recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. increased its position in shares of Mettler-Toledo International by 83.3% in the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 30 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Mettler-Toledo International by 7.7% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,680 shares of the medical instruments supplier’s stock worth $3,148,000 after purchasing an additional 192 shares during the last quarter. Impact Investors Inc increased its holdings in Mettler-Toledo International by 11.0% during the 2nd quarter. Impact Investors Inc now owns 313 shares of the medical instruments supplier’s stock valued at $368,000 after purchasing an additional 31 shares during the period. Valeo Financial Advisors LLC bought a new position in Mettler-Toledo International during the 2nd quarter valued at approximately $234,000. Finally, Slow Capital Inc. lifted its holdings in Mettler-Toledo International by 5.4% in the 2nd quarter. Slow Capital Inc. now owns 4,469 shares of the medical instruments supplier’s stock worth $5,249,000 after buying an additional 229 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.